SG48022A1 - Thioxanthenone antitumor agents - Google Patents

Thioxanthenone antitumor agents

Info

Publication number
SG48022A1
SG48022A1 SG1996006225A SG1996006225A SG48022A1 SG 48022 A1 SG48022 A1 SG 48022A1 SG 1996006225 A SG1996006225 A SG 1996006225A SG 1996006225 A SG1996006225 A SG 1996006225A SG 48022 A1 SG48022 A1 SG 48022A1
Authority
SG
Singapore
Prior art keywords
antitumor agents
thioxanthenone
thioxanthenone antitumor
thioxanthenones
disclosed
Prior art date
Application number
SG1996006225A
Other languages
English (en)
Inventor
Michael Elliot Ross
Theodore Charles Miller
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of SG48022A1 publication Critical patent/SG48022A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12—Thioxanthenes
    • C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16—Oxygen atoms, e.g. thioxanthones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996006225A 1991-06-10 1992-06-03 Thioxanthenone antitumor agents SG48022A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/713,172 US5091410A (en) 1991-06-10 1991-06-10 Thioxanthenone antitumor agents

Publications (1)

Publication Number Publication Date
SG48022A1 true SG48022A1 (en) 1998-04-17

Family

ID=24865076

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006225A SG48022A1 (en) 1991-06-10 1992-06-03 Thioxanthenone antitumor agents

Country Status (13)

Country Link
US (1) US5091410A (ja)
EP (1) EP0518413B1 (ja)
JP (1) JP3045355B2 (ja)
AT (1) ATE146172T1 (ja)
AU (1) AU643138B2 (ja)
CA (1) CA2070799C (ja)
DE (1) DE69215761T2 (ja)
DK (1) DK0518413T3 (ja)
ES (1) ES2098435T3 (ja)
GR (1) GR3022725T3 (ja)
IE (1) IE78824B1 (ja)
MX (1) MX9202752A (ja)
SG (1) SG48022A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346917A (en) * 1991-06-10 1994-09-13 Sterling Winthrop Inc. Thioxanthenone antitumor agents
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US10842776B2 (en) * 2016-06-28 2020-11-24 Assistance Publique—Hopitaua de Paris Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577441A (en) * 1967-03-07 1971-05-04 Warner Lambert Pharmaceutical Nitro substituted benzofurans
US3577558A (en) * 1968-04-15 1971-05-04 Sterling Drug Inc 1-aminoalkylamino-4-alkoxymethylthioxanthene derivatives
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
US4582851A (en) * 1984-02-06 1986-04-15 Warner-Lambert Company Anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, compositions, and method of use therefor
AU642596B2 (en) * 1991-06-10 1993-10-21 Sanofi-Synthelabo Thioxanthenone antitumor agents

Also Published As

Publication number Publication date
AU1704592A (en) 1992-12-17
EP0518413B1 (en) 1996-12-11
DK0518413T3 (da) 1997-06-02
ATE146172T1 (de) 1996-12-15
US5091410A (en) 1992-02-25
EP0518413A1 (en) 1992-12-16
JP3045355B2 (ja) 2000-05-29
CA2070799C (en) 2005-11-29
AU643138B2 (en) 1993-11-04
IE78824B1 (en) 1998-02-25
CA2070799A1 (en) 1992-12-11
IE921872A1 (en) 1992-12-16
ES2098435T3 (es) 1997-05-01
DE69215761T2 (de) 1997-06-05
DE69215761D1 (de) 1997-01-23
GR3022725T3 (en) 1997-06-30
JPH05262760A (ja) 1993-10-12
MX9202752A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
EG17765A (en) Method of treating tumors in mammals
DE69626513D1 (en) Imidazolverbindungen
EP0871494A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR CELLS
EP0709090A3 (en) Compositions for the treatment of resistant tumors
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
AU1110192A (en) Method and composition for treating reperfusion injury
EP0730449A4 (en) NOVEL PALLADIUM COMPLEXES AND METHODS OF USE THEREOF IN THE TREATMENT OF TUMORS AND PSORIASIS
NZ512210A (en) Camptothecin analogs useful for treating cancer and leukemia
ZA954984B (en) Compositions and methods for the treatment of tumors
SG48022A1 (en) Thioxanthenone antitumor agents
GB9010058D0 (en) Method and composition for the treatment of cancer
GB2185017A (en) Seco-sterol compounds effective in inducing the differentiation of malignant cells
IL106763A0 (en) Pharmaceutical compositions for treating cancer
HK51694A (en) Composition for treating pigmentation
GB9217547D0 (en) Leather treatment compositions
PL322103A1 (en) Benzopyraneindodiazolic anticaecinogenic agents
IL113444A0 (en) Compositions and methods for treating leukemia
AU7477791A (en) Method for treating cancer using combination chemotherapy and brm
ZA932731B (en) Method of treating gar-transformylase-dependent tumors
HU206980B (en) Process for producing composition suitable for treating phlebectasia and haemorrhoidal tumors
GB9007763D0 (en) Method and composition for the treatment of cancer
GB9112552D0 (en) Method and composition for the treatment of cancer